معرفی
Georgina Long is a Professor and Chair of Melanoma Medical Oncology & Translational Research at The University of Sydney's Faculty of Medicine and Health, affiliated with the Melanoma Institute Australia (MIA) and Royal North Shore Hospital. Her research focuses on targeted therapies and immuno-oncology in melanoma, with leadership in clinical trials and translational research. She holds a BSc (Hons), PhD in Chemistry, and MBBS (Hons) from the University of Sydney, followed by a Fulbright Postdoctoral Fellowship at Scripps Research Institute.
Her work spans clinical trials (Phase I-III), molecular biology of melanoma, and biomarker research. Notable roles include Past President of the Society for Melanoma Research, leadership in ASCO and ESMO committees, and editorial board memberships. Awards include 2024 Australian of the Year, Fellowship of the Australian Academy of Science, and Clarivate Highly Cited Researcher (2017–2024).
Research interests include melanoma subtypes, brain metastases, and immune checkpoint inhibitors. Over 570 peer-reviewed publications highlight her contributions to journals like NEJM, Lancet, and Science. Collaborations include international trials and translational studies linking molecular profiles to therapy response.
Awards and honors emphasize her global impact, including recognition for clinical and translational research excellence, leadership, and contributions to melanoma management. Her lab at MIA integrates clinical and laboratory research to advance patient outcomes.